World Orphan Drug Congress Europe
28 – 29 October, 2025 // Amsterdam, Netherlands
Join Worldwide Clinical Trials at World Orphan Drug Congress Europe.
62
days leftAbout event
WODC is a place to meet and brainstorm ways to advance orphan drug development and improve access to life-saving therapies. If you are attending, stop by booth #10311 and say hello to our team.
On 28 October, Derek Ansel, Vice President, Therapeutic Strategy Lead, Rare Disease, will present Creating Opportunity in the Chaos: Refocusing Patient Advocacy Efforts at 3:10 PM CET.
Nathan Chadwick, Senior Director, Therapeutic Strategy Lead, Rare Disease will lead Working Group #3 titled, “The Future of Cell & Gene Therapy for Rare Diseases,” at 11:30 AM CET.
Date
Tuesday to Wednesday
28 – 29 October, 2025
Venue
Amsterdam RAI
Europaplein 24, 1078 GZ Amsterdam, Netherlands
Derek Ansel
Vice President, Therapeutic Strategy Lead, Rare Disease
Derek Ansel, MS, LCGC, has worked in clinical research for more than 13 years with a focus almost exclusively on rare and pediatric diseases, including neurodevelopment disorders, non-malignant hematology, autoimmune diseases, metabolic disorders, movement disorders, and other genetic conditions. At Worldwide, he leads and supports corporate initiatives within rare and pediatric diseases, including genetic disorders, and cultivates relationships with over 120 patient-focused advocacy organizations.
